🔗 Share this article

Treasury head Reeves has revealed she is preparing "focused measures to deal with cost of living issues" in next month's financial statement.

Speaking to the BBC, she noted that curbing price rises is a joint duty of both the government and the Bank of England.

The United Kingdom's inflation rate is projected to be the highest among the Group of Seven developed nations this calendar year and the following year.

Potential Energy Bill Interventions

Reports indicate the government could intervene to reduce utility costs, for instance by cutting the present 5% level of value-added tax applied on energy.

An additional possibility is to lower some of the policy costs presently added to bills.

Budgetary Limitations and Expert Predictions

The government will receive the next report from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will reveal how much room there is for such measures.

The consensus from most analysts is that Reeves will have to announce tax increases or spending cuts in order to adhere to her voluntary debt limits.

Previously on Thursday, analysis indicated there was a twenty-two billion pound gap for the chancellor to fill, which is at the more modest range of forecasts.

"It is a shared task between the central bank and the government to further reduce some of the causes of price increases," Reeves informed the BBC in the US capital, at the yearly gatherings of the IMF and World Bank.

Revenue Commitments and International Issues

While much of the attention has been on likely tax rises, the chancellor said the most recent data from the fiscal watchdog had not altered her vow to campaign commitments not to raise rates on earnings tax, sales tax or social security contributions.

She attributed an "uncertain global environment" with rising international and commercial concerns for the Budget tax moves, probably to be targeted on those "with the broadest shoulders."

Global Economic Tensions

Referring to worries about the UK's economic relations with China she said: "Our security interests always take priority."

Recent announcement by Chinese authorities to tighten export controls on critical minerals and other resources that are key for advanced tech manufacturing led American leader the US President to propose an additional 100% tariff on goods from China, increasing the possibility of an full-scale commercial conflict between the two largest economies.

The US Treasury Secretary called the Chinese action "economic coercion" and "a global supply chain power grab."

Inquired about considering the American proposal to participate in its conflict with China, the Chancellor said she was "deeply worried" by Chinese measures and encouraged the Beijing authorities "not to put up barriers and limit trade."

She said the action was "bad for the world economy and generates further obstacles."

"It is my opinion there are fields where we need to address China, but there are also significant opportunities to trade with Chinese markets, including financial services and other sectors of the economy. We've got to maintain that balance correct."

The Treasury chief also affirmed she was collaborating with G7 counterparts "on our own essential resources plan, so that we are reduced dependence."

Health Service Drug Pricing and Investment

The Chancellor also admitted that the cost the National Health Service pays for pharmaceuticals could go up as a result of ongoing negotiations with the US government and its drugs companies, in exchange for reduced taxes and funding.

A number of the world's largest pharmaceutical manufacturers have said lately that they are either halting or scrapping projects in the United Kingdom, with some blaming the modest returns they are getting.

Last month, the government science advisor said the cost the health service spends on medicines would must go up to halt firms and pharmaceutical investment leaving the United Kingdom.

Reeves told media: "It has been observed due to the cost structure, that medical research, innovative medicines have not been offered in the United Kingdom in the manner that they are in other continental states."

"We want to guarantee that patients receiving treatment from the National Health Service are can access the finest critical medicines in the globe. And so we are reviewing these issues, and... aiming to obtain increased investment into the UK."